
| Pair Name | Usnic acid, Bleomycin | ||
| Phytochemical Name | Usnic acid (PubChem CID: 5646 ) | ||
| Anticancer drug Name | Bleomycin (PubChem CID: 5360373 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Usnic acid, Bleomycin | |||
| Disease Info | [ICD-11: 2F94] | Ascitic tumor | Investigative | |
| Biological Phenomena | Induction-->Blockade of cell cycle in G0/G1 phase | |||
| Gene Regulation | Down-regulation | Expression | SMAD2 | hsa4087 |
| Up-regulation | Expression | SMAD3 | hsa4088 | |
| Up-regulation | Expression | SMAD7 | hsa4092 | |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Up-regulation | Cleavage | CASP8 | hsa841 | |
| Up-regulation | Expression | CDKN1A | hsa1026 | |
| Up-regulation | Expression | TP53 | hsa7157 | |
| Down-regulation | Expression | CCND1 | hsa595 | |
| Down-regulation | Expression | CCNE1 | hsa898 | |
| Down-regulation | Expression | SOD1 | hsa6647 | |
| Up-regulation | Expression | PHEX | hsa5251 | |
| Up-regulation | Expression | TNF | hsa7124 | |
| Up-regulation | Expression | IL1B | hsa3553 | |
| Up-regulation | Expression | IL6 | hsa3569 | |
| Up-regulation | Expression | TGFB1 | hsa7040 | |
| In Vitro Model | H22 | Hepatocellular carcinoma | Mus musculus (Mouse) | CVCL_H613 |
| In Vivo Model | Mice in Model, BLM, UA and UA + BLM groups were inoculated with H22 cells (0.2 mL, 2×10⁶ cells/mouse, i.p.) to establish malignant ascites tumor-bearing mouse model. | |||
| Result | Effect-enhancing and toxicity-reducing activity of usnic acid in ascitic tumor-bearing mice treated with bleomycin | |||
| No. | Title | Href |
|---|---|---|
| 1 | Effect-enhancing and toxicity-reducing activity of usnic acid in ascitic tumor-bearing mice treated with bleomycin. Int Immunopharmacol. 2017 May;46:146-155. doi: 10.1016/j.intimp.2017.03.004. | Click |